drugset / Trial / NCT00081757

An Open Protocol for the Compassionate Use of Thalidomide

NCT00081757

Phase 1/2 Completed 250 enrolled University of Arkansas
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the use of thalidomide for the treatment of cancer. Patients with many types of cancers will be enrolled because the researchers will also study how the different cancers respond and what kind of side effects patients will experience.

Timeline

Start
1998-09
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Thalidomide Other / unclassified

Indications